Performance of Toric Hydrogel Lenses Following A Refit With Toric Silicone Hydrogel Lenses for 1 Month
- Disease/Condition
- Ametropia
- Drug/Device/Intervention
- methafilcon A toric contact lenses
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Coopervision, Inc.
- Location
- Mexico City, Mexico
- Phase
- N/A
- Start date
- Jan 01, 2019
- End date
- Jul 06, 2019
- Enrollment
- 43 participants
Number of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Methalfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Methalfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Toric Contact Lenses
The aim of this prospective study is to evaluate the clinical performance of habitual wearers
 of methafilcon A toric lenses after a refit with fanfilcon A toric lenses for 1-month of
 daily wear.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT03835221
- Type
- Device Trial
Access comprehensive clinical trial information for NCT03835221 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 43 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.